SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-24-088114
Filing Date
2024-04-05
Accepted
2024-04-05 10:40:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d812271dposam.htm POS AM 18804
  Complete submission text file 0001193125-24-088114.txt   19832
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-272509 | Film No.: 24825156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)